umu.sePublications
Change search
CiteExportLink to record
Permanent link

Direct link
Cite
Citation style
  • apa
  • ieee
  • modern-language-association-8th-edition
  • vancouver
  • Other style
More styles
Language
  • de-DE
  • en-GB
  • en-US
  • fi-FI
  • nn-NO
  • nn-NB
  • sv-SE
  • Other locale
More languages
Output format
  • html
  • text
  • asciidoc
  • rtf
The IMSE 2 study: a Swedish nationwide pharmaco-epidemiological and genetic study focused on long-term safety and efficacy of fingolimod
Show others and affiliations
2015 (English)In: Multiple Sclerosis, ISSN 1352-4585, E-ISSN 1477-0970, Vol. 21, 284-285 p.Article in journal, Meeting abstract (Other academic) Published
Resource type
Text
Place, publisher, year, edition, pages
2015. Vol. 21, 284-285 p.
National Category
Neurosciences Neurology
Identifiers
URN: urn:nbn:se:umu:diva-113872ISI: 000365729400489OAI: oai:DiVA.org:umu-113872DiVA: diva2:911960
Conference
31st Congress of the European-Committee-for-Treatment-and-Research-in-Multiple-Sclerosis (ECTRIMS), OCT 07-10, 2015, Barcelona, SPAIN
Available from: 2016-03-15 Created: 2016-01-04 Last updated: 2016-03-15Bibliographically approved

Open Access in DiVA

No full text

Search in DiVA

By author/editor
Svenningsson, Anders
By organisation
Clinical Neuroscience
In the same journal
Multiple Sclerosis
NeurosciencesNeurology

Search outside of DiVA

GoogleGoogle Scholar

Total: 26 hits
CiteExportLink to record
Permanent link

Direct link
Cite
Citation style
  • apa
  • ieee
  • modern-language-association-8th-edition
  • vancouver
  • Other style
More styles
Language
  • de-DE
  • en-GB
  • en-US
  • fi-FI
  • nn-NO
  • nn-NB
  • sv-SE
  • Other locale
More languages
Output format
  • html
  • text
  • asciidoc
  • rtf